Home › Funds › Avoro Capital Advisors LLC › KYMR

Avoro Capital Advisors LLC position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Avoro Capital Advisors LLC reported holding 7,474,747 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$835.6M, representing 8.65% of its reported portfolio and ranking #6 among its reported holdings. Avoro Capital Advisors LLC has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.47M sh
Reported value held$835.60M
Portfolio Weight8.65%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's KYMR position evolved

Avoro Capital Advisors LLC first disclosed a stake in KYMR in Q3 2023 at 3,855,000 shares (US$53.6M). The position peaked in Q2 2026 at 7,474,747 shares, worth US$857.1M. Across 13 filings, Avoro Capital Advisors LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 7,474,747 shares valued at US$835.6M. Notable position changes include a 25% increase in Q1 2025 (shares rose 59% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.85M $53.58M New
Q4 2023 3.77M $96.11M Reduce
Q1 2024 3.89M $156.33M Add
Q2 2024 3.89M $116.08M Hold
Q3 2024 4.50M $212.99M Add
Q4 2024 5.15M $207.18M Add
Q1 2025 6.46M $176.81M Add
Q2 2025 6.56M $286.08M Add
Q3 2025 6.35M $359.41M Reduce
Q4 2025 7.47M $581.61M Add
Q1 2026 7.47M $622.57M Hold
Q2 2026 7.47M $857.13M Hold
Q3 2026 7.47M $835.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), T. Rowe Price Investment Management, Inc. (US$717.5M), BVF INC/IL (US$444.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Avoro Capital Advisors LLC held KYMR?

Avoro Capital Advisors LLC has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Avoro Capital Advisors LLC's current position in KYMR?

As of Q3 2026, Avoro Capital Advisors LLC holds 7.47M shares of KYMR (KYMERA THERAPEUTICS INC), valued at $835.60M, representing 8.65% of its reported portfolio and ranking #6.

Has Avoro Capital Advisors LLC been buying or selling KYMR?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in KYMR. The position peaked in Q2 2026 at 7.47M shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, T. Rowe Price Investment Management, Inc., BVF INC/IL, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.